sublingual semaglutide drops – Intermountain HCG 🚨 New at WeightCare: Sublingual

For weight management, the FDA-approved options are Wegovy (semaglutide), Zepbound (tirzepatide), and Foundayo (orforglipron)

Jang, G

Treatment Landscape Today, obesity therapies consist of lifestyle changes, surgery, and drugs like GLP-1 agonists

Research suggests: Synergistic effects on weight loss exceeding predictions from single or dual receptor activation Complementary regulation of both energy intake (primarily GLP-1 and GIP) and energy expenditure (primarily glucagon) Balanced effects on glucose metabolism through multiple mechanisms Potential cardiovascular benefits through lipid metabolism improvements and blood pressure reduction [CALLOUT BOX Highlighted] Mechanistic Insight: GLP3 s triagonist approach represents an evolution beyond dual GLP-1/GIP agonism, with the addition of glucagon receptor activation appearing to enhance weight loss efficacy and metabolic benefits